Membres de l'équipe

GALES
Céline
(DR2)

GALES Céline (DR2)

celine.gales@inserm.fr

+33531224081

SENARD
Jean-Michel
(PUPH)

SENARD Jean-Michel (PUPH)

jean-michel.senard@inserm.fr

+33531224075

PONS
Véronique
(CR1)

PONS Véronique (CR1)

veronique.pons@inserm.fr

+330531224072

ARVANITIS
Constandina
(CR1)

ARVANITIS Constandina (CR1)

constandina.arvanitis@inserm.fr

+33531224072

SEGUELAS
Marie-Hélène
(ITA)

SEGUELAS Marie-Hélène (ITA)

marie-helene.seguelas@inserm.fr

+33531224074

NGUYEN
Du
(ITA)

NGUYEN Du (ITA)

du.nguyen@inserm.fr

+33531224074

CAUQUIL
Marie
(DOC)

CAUQUIL Marie (DOC)

marie.cauquil@inserm.fr

+33531224072

PATHAK
Atul
(PUPH)

PATHAK Atul (PUPH)

atul.pathak@univ-tlse3.fr

+33531224075

POIROT
Mathias
(DOC)

POIROT Mathias (DOC)

mathias.poirot@inserm.fr

+33531224072

LABRUNEE
Marc
(PH)

LABRUNEE Marc (PH)

marc.labrunee@inserm.fr

+33531224075

MAURY
Philippe
(PUPH)

MAURY Philippe (PUPH)

maury.p@chu-toulouse.fr

+33531224075

KARSENTY
Clément
(DOC)

KARSENTY Clément (DOC)

clement.karsenty@inserm.fr

+33531224072

BESNIER
FLorent
(DOC)

BESNIER FLorent (DOC)

florent.besnier@hotmail.fr

+33531224075

GUILBEAU-FRUGIER
Céline
(MCUPH)

GUILBEAU-FRUGIER Céline (MCUPH)

guilbeau-frugier.c@chu-toulouse.fr

+33531224081

HASCOET
Sébastien
(PH)

HASCOET Sébastien (PH)

sebastien.hascoet@inserm.fr

+33531224075

NASR
Nathalie
(MCUPH)

NASR Nathalie (MCUPH)

nathalie.nasr@inserm.fr

+33531224075

PAVY-LE TRAON
Anne
(PH)

PAVY-LE TRAON Anne (PH)

pavy-letraon.a@chu-toulouse.fr

KERMORGANT
Marc
(post-doc)

KERMORGANT Marc (post-doc)

marckermorgant@yahoo.fr

+33531224075

GUIRAUD
Thibaut
(MAST)

GUIRAUD Thibaut (MAST)

thibaut.guiraud@inserm.fr

+33531224075

SEGURA
Emilie
(DOC)

SEGURA Emilie (DOC)

emilie.segura@inserm.fr

+33531224072

PMIDTitreAuteursAnnéeJournal
27107932Delineating biased ligand efficacy at 7TM receptors from an experimental perspective.GALANDRIN S, ONFROY L, POIROT MC; SÉNARD JM, GALES C2016Int J Biochem Cell Biol
26921945Analysis of Arrestin Recruitment to Chemokine Receptors by Bioluminescence Resonance Energy TransferBONNETERRE J, MONTPAS N, BOULARAN C, GALÉS C, HEVEKER N2016Methods Enzymol.
27716822Signaling Properties of Chemerin Receptors CMKLR1, GPR1 and CCRL2.1. DE HENAU O, DEGROOT GN, IMBAULT V, ROBERT V, DE POORTER C, MCHEIK S, GALÉS C, PARMENTIER M, SPRINGAEL JY. 2016Plos One
27895119Partial agonist and biased signaling properties of the synthetic enantiomers J113863/UCB35625 at chemokine receptors CCR2 and CCR5.CORBISIER J, HUSZAGH A, GALÉS C, PARMENTIER M, SPRINGAEL JY. 2016J Biol Chem
27650531Whole-body strength training with Huber Motion Lab and traditional strength training in cardiac rehabilitation: A randomized controlled studyGUIRAUD T, LABRUNÉE M, BESNIER F, SÉNARD JM, PILLARD F, RIVIÈRE D, RICHARD L, LAROCHE D, SANGUIGNOL F, PATHAK A, GAYDA M, GREMEAUX V.2016Ann Phys Rehabil Med
27895119Partial agonist and biased signaling properties of the synthetic enantiomers J113863/UCB35625 at chemokine receptors CCR2 and CCR5.CORBISIER J, HUSZAGH A, GALÉS C, PARMENTIER M, SPRINGAEL JY. 2016J Biol Chem
27650531Whole-body strength training with Huber Motion Lab and traditional strength training in cardiac rehabilitation: A randomized controlled studyGUIRAUD T, LABRUNÉE M, BESNIER F, SÉNARD JM, PILLARD F, RIVIÈRE D, RICHARD L, LAROCHE D, SANGUIGNOL F, PATHAK A, GAYDA M, GREMEAUX V.2016Ann Phys Rehabil Med
27895119Partial agonist and biased signaling properties of the synthetic enantiomers J113863/UCB35625 at chemokine receptors CCR2 and CCR5.CORBISIER J, HUSZAGH A, GALÉS C, PARMENTIER M, SPRINGAEL JY. 2016J Biol Chem
27650531Whole-body strength training with Huber Motion Lab and traditional strength training in cardiac rehabilitation: A randomized controlled studyGUIRAUD T, LABRUNÉE M, BESNIER F, SÉNARD JM, PILLARD F, RIVIÈRE D, RICHARD L, LAROCHE D, SANGUIGNOL F, PATHAK A, GAYDA M, GREMEAUX V.2016Ann Phys Rehabil Med
27698068Cardioprotective Angiotensin-(1-7) Peptide Acts as a Natural-Biased Ligand at the Angiotensin II Type 1 ReceptorGALANDRIN et al2016Hypertension
26483685Cardiac cAMP: production, hydrolysis, modulation and detectionBOULARAN C, GALES C2015Frontiers in Pharmacology
26183201Physical activity prescription for improving health in patients with cardiometabolic risk: Using empirical evidence to provide clear public health messages.GUIRAUD T, LABRUNÉE M, PATHAK A, PILLARD F, STAPLEY PJ, GREMEAUX V2015Ann Phys Rehabil Med
26658454The experimental power of FR900359 to study Gq-regulated biological processesSCHRAGE R, SCHMITZ AL, GAFFAL E, ANNALA S, KEHRAUS S, WENZEL D, BÜLLESBACH KM, BALD T, INOUE A, SHINJO Y, GALANDRIN S, SHRIDHAR N, HESSE M, GRUNDMANN M, MERTEN N, CHARPENTIER TH, MARTZ M, BUTC2015Nat Commun
26363071Agonism, Antagonism, and Inverse Agonism Bias at the Ghrelin Receptor SignalingM Kadmi C, Leyris JP, Onfroy L, Galés C, Saulière A, Gagne D, Damian M, Mary S, Maingot M, Denoyelle S, Verdié P, Fehrentz JA, Martinez J, Banères JL, Marie J2015J Biol Chem
26634369High intake of dietary tyramine does not deteriorate glucose handling and does not cause adverse cardiovascular effects in miceCARPÉNÉ C, SCHAAK S, GUILBEAU-FRUGIER C, MERCADER J, MIALET-PEREZ J2015J Physiol Biochem
25171664Whole-body strength training using a Huber Motion Lab in coronary heart disease patients: safety, tolerance, fuel selection, and energy expenditure aspects and optimizationGUIRAUD T, LABRUNÉE M, PILLARD F, GRANGER R, BOUSQUET M, RICHARD L, BONED A, PATHAK A, GAYDA M, GREMEAUX V2015Am J Phys Med Rehabil
25802954Improved Walking Claudication Distance with Transcutaneous Electrical Nerve Stimulation: An Old Treatment With a New Indication In Patients with Peripheral Artery DiseaseLABRUNÉE M, BONED A, GRANGER R, BOUSQUET M, JORDAN C, RICHARD L, GARRIGUES D, GREMEAUX V, PHD, SÉNARD JM, PATHAK A, GUIRAUD T2015Am J Phys Med Rehab
25706338Dual agonist occupancy of AT1-R-α2C-AR heterodimers results in atypical Gs-PKA signalingBELLOT M, GALANDRIN S, BOULARAN C, MATTHIES HJ, DESPAS F, DENIS C, JAVITCH J, MAZÈRES S, SANNI SJ, PONS V, SEGUELAS MH, HANSEN JL, PATHAK A, GALLI A, SÉNARD JM, GALÉS C2015Nat Chem Biol
25617475An essential role for RGS protein/Gαi2 interactions in B lymphocyte-directed cell migration and traffickingHWANG IY, PARK C, HARRISON K, BOULARAN C, GALÉS C, KEHRL JH2015J Immunol
26298415Renal sympathetic nerve denervation using intraluminal ultrasound within a cooling balloon preserves the arterial wall and reduces sympathetic nerve activityPATHAK A, COLEMAN L, ROTH A, STANLEY J, BAILEY L, MARKHAM P, EWEN S, MOREL C, DESPAS F, HONTON B, SENARD JM, FAJADET J, MAHFOUD F2015Eurointervention
25375203Β2-adrenergic receptor regulates proliferation, adhesion and migration of tumor and non tumor breast cell linesGARGIULO L, COPSEL S, RIVERO EM, GALÉS C, SENARD JM, DAVIO C, LÜTHY IA, BRUZZONE A2014Oncotarget
24308976Dosage-dependent regulation of cell proliferation and adhesion through dual β2-adrenergic receptor/cAMP signals.Bruzzone A, Saulière A, Finana F, Sénard JM, Lüthy I, Galés C2014FASEB J
24839910Atomic force and electron microscopic-based study of sarcolemmal surface of living cardiomyocytes unveils unexpected mitochondrial shift in heart failure.DAGUE E, GENET G, LACHAIZE V, GUILBEAU-FRUGIER C, FAUCONNIER J, MIAS C, PAYRÉ B, CHOPINET L, ALSTEENS D, KASAS S, SEVERAC C, THIREAU J, HEYMES C, HONTON B, LACAMPAGNE A, PATHAK A, SÉNARD2014J Mol Cell Cardiol.
24667435Direct evidences for sympathetic hyperactivity and baroreflex impairment in Tako Tsubo cardiopathy. VACCARO A., DESPAS F, DELMAS C, LAIREZ O, LAMBERT E, LAMBERT G, LABRUNEE M, GUIRAUD T, ESLER M, GALINIER M, SENARD JM, PATHAK A. 2014Plos One
24244423Cardiac fibroblasts regulate sympathetic nerve sprouting and neurocardiac synapse stabilityMIAS C, COATRIEUX C, DENIS C, SEGUELAS MH, LAPLACE N, ROUZAUD-LABORDE C, CALISE D, PARINI A, CUSSAC D, PATHAK A, SENARD JM, GALES C. 2013Plos One
24265770Acute electromyostimulation decreases muscle sympathetic nerve activity in patients with advanced chronic heart failure (EMSICA study)LABRUNEE M, DESPAS F, MARQUE P, GUIRAUD T, GALINIER M, SENARD JM, PATHAK A. 2013Plos One
23591293High-Intensity Interval Exercise Improves Vagal Tone and Decreases Arrhythmias in Chronic Heart Failure. GUIRAUD T, LABRUNEE M, GAUCHER-CAZALIS K, DESPAS F, MEYER P, BOSQUET L, GALES C, VACCARO A, BOUSQUET M, GALINIER M, SÉNARD JM, PATHAK A2013Med Sci Sports Exerc.
23594161Pharmacology of levosimendan: inotropic, vasodilatory and cardioprotective effects.PATHAK A, LEBRIN M, VACCARO A, SENARD JM, DESPAS F.2013J Clin Pharm Ther
23781941Bortezomib and heart failure: case-report and review of the French Pharmacovigilance database. HONTON B, DESPAS F, DUMONTEIL N, ROUVELLAT C, ROUSSEL M, CARRIE D, GALINIER M, MONTASTRUC JL, PATHAK A. 2013Fundam Clin Pharmacol
23415171Cardiorenal Anaemia Syndrome in Chronic Heart Failure contributes to increased sympathetic nerve activity. FRANCHITTO N, DESPAS F, LABRUNEE M, VACCARO A, LAMBERT E, LAMBERT G, GALINIER M, SENARD JM, PATHAK A. 2013Int J Cardiol
24139928Transcatheter aortic valve implantation (TAVI) reduces sympathetic activity and normalizes arterial spontaneous baroreflex in patients with aortic stenosis.DUMONTEIL N, VACCARO A, DESPAS F, LABRUNEE M, MARCHEIX B, E LAMBERT E, ESLER M, CARRIE D, SENARD JM, GALINIER M, PATHAK A. 2013JACC Cardiovasc Interv.
23544370Adult cardiomyocytes wake up: a big step towards cardiac regeneration. MIAS C, GALÉS C. 2013Med Sci
22634635Deciphering biased-agonism complexity reveals a new active AT1 receptor entity.Saulière A, Bellot M, Paris H, Denis C, Finana F, Hansen JT, Altié MF, Seguelas MH, Pathak A, Hansen JL, Sénard JM, Galés C2012Nat Chem Biol
23290411Adult resident cardiomyocytes wake up: new axis for cardiac tissue regeneration.MIAS C, GENET G, PATHAK A, SÉNARD JM, GALÉS C.2012Med Sci.
22302788Ephrin-B1 Is a Novel Specific Component of the Lateral Membrane of the Cardiomyocyte and Is Essential for the Stability of Cardiac Tissue Architecture Cohesion.GENET G, GUILBEAU-FRUGIER C, HONTON B, DAGUE E, SCHNEIDER MD, COATRIEUX C, CALISE D, CARDIN C, NIETO C, PAYRE B, DUBROCA C, MARCK P, HEYMES C, DUBRAC A, ARVANITIS A, DESPAS F, ALTIE MF, SEGUELAS MH, D2012Circ Res
21419153G protein-coupled receptors, an unexploited animal toxin targets: Exploration of green mamba venom for novel drug candidates active against adrenoceptors. MAÏGA A, MOURIER G, QUINTON L, ROUGET C, GALES C, DENIS C, LLUEL P, SÉNARD JM, PALEA S, SERVENT D, GILLES N.2012Toxicon
22241144Peripheral chemoreflex activation contributes sympathetic baroreflex impairment in chronic heart failure. DESPAS F, LAMBERT E, VACCARO A, LABRUNEE M, FRANCHITTO N, LEBRIN M, GALINIER M, SENARD JM, LAMBERT G, ESLER M, PATHAK A. 2012J Hypertens
22229559Probing heterotrimeric G protein activation : applications to biased ligands.DENIS C, SAULIERE A, GALANDRIN S, SENARD JM, GALES C. 2012Curr Pharm Des.
22069312Functional selective oxytocin-derived agonists discriminate between individual G protein family subtypes. BUSNELLI M, SAULIERE A, MANNING M, BOUVIER M, GALES C, CHINI B. 2011J Biol Chem.
20194300Tonic chemoreflex activation contributes to increased sympathetic nerve activity in heart failure-related anaemia. FRANCHITTO N, DESPAS F, LABRUNEE M, RONCALLI J, GALINIER M, BOVEDA S, SENARD JM, PATHAK A. 2010Hypertension
20044275Limited prognostic value of cardiac metaiodobenzylguanidine in advanced heart failure.DESPAS F, GUERRIERO E, GALINIER M, SENARD JM, PATHAK A. 2010J Heart Lung Transplant
20063034DBH deficiency in an elderly patient: efficacy and safety of chronic droxidopa, DESPAS F, PATHAK A, BERRY M, CAGNAC R, MASSABUAU P, LIOZON E, GALINIER M, SENARD JM2010Clin Auton Res
19929264Levosimendan improves hemodynamics functions without sympathetic activation in severe heart failure patients : direct evidence from sympathetic neural recording.DESPAS F, TROUILLET C, FRANCHITTO N, LABRUNEE M, GALINIER M, SENARD JM, PATHAK A. 2010Acute Card Care